92 related articles for article (PubMed ID: 20979878)
1. [Analysis on clinical characteristics of rectal neuroendocrine tumors].
Wang HB; Wang LP
Zhonghua Yi Xue Za Zhi; 2010 Jun; 90(24):1686-9. PubMed ID: 20979878
[TBL] [Abstract][Full Text] [Related]
2. Clinicopathological characteristics and frequency of multiple rectal neuroendocrine tumors: a single-center retrospective study.
Nishikawa Y; Chino A; Ide D; Saito S; Igarashi M; Takamatsu M; Fujisaki J; Igarashi Y
Int J Colorectal Dis; 2019 Nov; 34(11):1887-1894. PubMed ID: 31630212
[TBL] [Abstract][Full Text] [Related]
3. Clinical outcomes of rectal neuroendocrine tumors ≤ 10 mm following endoscopic resection.
Kim GU; Kim KJ; Hong SM; Yu ES; Yang DH; Jung KW; Ye BD; Byeon JS; Myung SJ; Yang SK; Kim JH
Endoscopy; 2013 Dec; 45(12):1018-23. PubMed ID: 24288222
[TBL] [Abstract][Full Text] [Related]
4. Analysis of the factors affecting lymph node metastasis and the prognosis of rectal neuroendocrine tumors.
Li P; Wu F; Zhao H; Dou L; Wang Y; Guo C; Wang G; Zhao D
Int J Clin Exp Pathol; 2015; 8(10):13331-8. PubMed ID: 26722537
[TBL] [Abstract][Full Text] [Related]
5. The novel WHO 2010 classification for gastrointestinal neuroendocrine tumours correlates well with the metastatic potential of rectal neuroendocrine tumours.
Jernman J; Välimäki MJ; Louhimo J; Haglund C; Arola J
Neuroendocrinology; 2012; 95(4):317-24. PubMed ID: 22327359
[TBL] [Abstract][Full Text] [Related]
6. Metastatic 5-mm rectal neuroendocrine carcinoma.
Cuicchi D; Lecce F; Campana D; Cola B
Dig Liver Dis; 2011 Nov; 43(11):e25. PubMed ID: 21664197
[No Abstract] [Full Text] [Related]
7. Neuroendocrine tumors of midgut and hindgut origin: tumor-node-metastasis classification determines clinical outcome.
Jann H; Roll S; Couvelard A; Hentic O; Pavel M; Müller-Nordhorn J; Koch M; Röcken C; Rindi G; Ruszniewski P; Wiedenmann B; Pape UF
Cancer; 2011 Aug; 117(15):3332-41. PubMed ID: 21246527
[TBL] [Abstract][Full Text] [Related]
8. A retrospective clinico-pathological analysis of neuroendocrine tumors of the gastrointestinal tract.
Amarapurkar DN; Juneja MP; Patel ND; Amarapurkar AD; Amarapurkar PD
Trop Gastroenterol; 2010; 31(2):101-4. PubMed ID: 20862983
[TBL] [Abstract][Full Text] [Related]
9. Role of imaging in the preoperative staging of small bowel neuroendocrine tumors.
Chambers AJ; Pasieka JL; Dixon E; Rorstad O
J Am Coll Surg; 2010 Nov; 211(5):620-7. PubMed ID: 21035044
[TBL] [Abstract][Full Text] [Related]
10. Clinicopathological characteristics of rectal multiple neuroendocrine neoplasms and literature review.
Zheng X; Wu M; Li S; Er L; Deng H; Guo S; Liu Z
BMC Surg; 2023 Jun; 23(1):147. PubMed ID: 37264328
[TBL] [Abstract][Full Text] [Related]
11. Updating the management of patients with rectal neuroendocrine tumors.
de Mestier L; Brixi H; Gincul R; Ponchon T; Cadiot G
Endoscopy; 2013 Dec; 45(12):1039-46. PubMed ID: 24163193
[TBL] [Abstract][Full Text] [Related]
12. Epicardial metastasis of rectal neuroendocrine tumour.
Kwon JT; Lee DH; Jung TE; Gu MJ
Eur J Cardiothorac Surg; 2014 Sep; 46(3):504. PubMed ID: 24401688
[No Abstract] [Full Text] [Related]
13. Clinical characteristics, risk factors and outcomes of asymptomatic rectal neuroendocrine tumors.
Ko SH; Baeg MK; Ko SY; Jung HS
Surg Endosc; 2017 Oct; 31(10):3864-3871. PubMed ID: 28078467
[TBL] [Abstract][Full Text] [Related]
14. Somatostatin-producing neuroendocrine tumors of the duodenum and pancreas: incidence, types, biological behavior, association with inherited syndromes, and functional activity.
Garbrecht N; Anlauf M; Schmitt A; Henopp T; Sipos B; Raffel A; Eisenberger CF; Knoefel WT; Pavel M; Fottner C; Musholt TJ; Rinke A; Arnold R; Berndt U; Plöckinger U; Wiedenmann B; Moch H; Heitz PU; Komminoth P; Perren A; Klöppel G
Endocr Relat Cancer; 2008 Mar; 15(1):229-41. PubMed ID: 18310290
[TBL] [Abstract][Full Text] [Related]
15. Endoscopic ultrasound-guided fine-needle aspiration cytology of pancreatic neuroendocrine tumors: a study of 48 cases.
Chatzipantelis P; Salla C; Konstantinou P; Karoumpalis I; Sakellariou S; Doumani I
Cancer; 2008 Aug; 114(4):255-62. PubMed ID: 18618505
[TBL] [Abstract][Full Text] [Related]
16. Rectal cancer with an extension outside mesorectum but curable.
Takahashi T; Azekura K; Ohta H; Ueno M
Acta Chir Iugosl; 1998; 45(2 Suppl):49-52. PubMed ID: 10951788
[No Abstract] [Full Text] [Related]
17. PROX1 is involved in progression of rectal neuroendocrine tumors, NETs.
Jernman J; Kallio P; Hagström J; Välimäki MJ; Haapasalo H; Alitalo K; Arola J; Haglund C
Virchows Arch; 2015 Sep; 467(3):279-84. PubMed ID: 26063416
[TBL] [Abstract][Full Text] [Related]
18. [Relevant factors of lymphatic metastasis in rectal carcinoma].
Yu D; Li TG; Yao HL; Zhao H; Liu GQ; Pi ZM
Zhong Nan Da Xue Xue Bao Yi Xue Ban; 2006 Feb; 31(1):128-30. PubMed ID: 16562693
[TBL] [Abstract][Full Text] [Related]
19. Recurrence 30 Years after Surgical Resection of a Localized Rectal Neuroendocrine Tumor.
Shigematsu Y; Kanda H; Konishi T; Takazawa Y; Inoue Y; Muto T; Ishikawa Y; Takahashi S
Intern Med; 2017; 56(12):1521-1525. PubMed ID: 28626177
[TBL] [Abstract][Full Text] [Related]
20. Angiopoietin-2 promotes disease progression of neuroendocrine tumors.
Detjen KM; Rieke S; Deters A; Schulz P; Rexin A; Vollmer S; Hauff P; Wiedenmann B; Pavel M; Scholz A
Clin Cancer Res; 2010 Jan; 16(2):420-9. PubMed ID: 20068079
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
